Market News & Trends
SMARTag Toxicology Study Demonstrates Decreased Mortality & Better Tolerability
Redwood Bioscience and Catalent Pharma Solutions recently announced the results of an in vivo toxicology study, demonstrating that an Antibody Drug Conjugate (ADC) generated using…
Tech Group Receives 2014 Lilly Global Supplier Award
West Pharmaceutical Services, Inc. recently announced that its Tech Group Rockford facility has received a 2014 Lilly Global Supplier Award. Lilly presented the award at…
Crown Bioscience Reveals Strategy for Combining Drug Therapy With Irradiation
Crown Bioscience, Inc. has developed treatment combination strategies with image-guided micro-irradiation (IGMI) to overcome drug resistance. These novel strategies at the preclinical stage of drug…
EMD Millipore Launches RNA Reprogramming Technology
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, recently launched Simplicon RNA Reprogramming Technology, which uses synthetic self-replicating RNA to create…
CEA-Leti & Akrivis Technologies to Develop Nanomedicine Platform for High Payload Targeted Drug Delivery
CEA-Leti and Akrivis Technologies, LLC recently announced their collaboration to develop an extremely adaptable, efficient, and highly targeted drug delivery platform for chemotherapy and other…
Can Regenerative Medicine be the Cure for Cancer & Other Deadly Diseases?
Regenerative medicine has the potential to transform healthcare all over the world and usher human health into a new era of wellness. Currently, the majority…
Exostar & SAFE-BioPharma Announce Strategic Partnership
Exostar and SAFE-BioPharma Association recently announced a new partnership that will enable Exostar to issue non-public key infrastructure (PKI) identity credentials at Levels of Assurance…
Oxford Biomedical Research Centre Signs Contract With GENALICE
GENALICE recently announced that the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre’s Molecular Diagnostics Centre has signed a contract for a larger…
Can Regenerative Medicine be the Cure for Cancer & Other Deadly Diseases?
Regenerative medicine has the potential to transform healthcare all over the world and usher human health into a new era of wellness. Currently, the majority…
Delivering Value From Drug-Device Strategic Partnerships
By: Alan Shortall, Chairman and CEO of Unilife The formation of a strategic alliance this week between Sanofi and Medtronic to enhance the provision of…
Isis Pharmaceuticals Earns $15 Million From AstraZeneca
Isis Pharmaceuticals, Inc.recently announced that AstraZeneca has initiated a Phase I clinical study of ISIS-ARRx in patients with cancer. Isis earned a $15-million milestone payment…
Aduro Biotech Secures $55 Million Series C Financing
Aduro BioTech, Inc. recently announced the closing of a $55 million Series C financing. New investor Johnson & Johnson Development Corporation (JJDC) joined the Morningside…
Ligand Partner GSK Announces Results of Phase III PETIT2 Study
Ligand Pharmaceuticals Incorporated recently announced that its partner, GlaxoSmithKline (GSK) plc, presented the results from the Phase III PETIT2 study evaluating the efficacy of eltrombopag…
Lucrative Biosimilars Space to Erode Biologics Market From 2019
The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate…
Xcelience Opens UK/European Packaging & Distribution Hub
Xcelience recently announced the opening of a 3,000-sq-ft facility in Birmingham, UK, making it the first small- to mid-sized American CDMO to launch international operations.…
Celgene Exercises Option for Agios Pharmaceuticals’ Lead Cancer Drug
Agios Pharmaceuticals, Inc. recently announced its partner Celgene Corporation has exercised its option to an exclusive worldwide license to AG-221, an oral, first-in-class, potent inhibitor…
Lucrative Biosimilars Space to Erode Biologics Market From 2019
The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate…
Lubrizol Introduces New Pharmaceutical Excipient
The Lubrizol LifeScience Polymers (LSP) business announces the introduction of a new pharmaceutical-grade excipient, Pathway. As pharmaceutical companies face the challenge of the patent cliff,…
Agalimmune Receives $2-Million) Milestone Payment
Agalimmune Ltd recently announced it has received a milestone payment from Loxbridge Research LLP and Animatrix Finance Ltd following successful completion of two Phase I…
Key Patent Expiries to Lead Global Anti-Hypertensive Market
Multiple major drug patent expiries will cause the global anti-hypertensive market value to decline from $40 billion in 2013 to $37.6 billion by 2020, at…
